Tsumura & Company Overview
- Founded
- 1893
- Status
- Public
- Employees
- 5,074
- Stock Symbol
- 4540
- Investments
- 1
- Share Price
- $29.94
- (As of Friday Closing)
Tsumura & Company General Information
Description
Tsumura & Co is a specialty and generic drug manufacturing company. The company generates most of its revenue through prescription Kampo products, followed by over-the-counter medicines. Tsumura promotes its products through educational support at medical schools and by hosting seminars for physicians and consumers. The company considers strategic collaboration agreements to be a potential component of its operational growth strategy for expanding its research, development, manufacturing, and marketing capabilities.
Contact Information
Primary Industry
Pharmaceuticals
Stock Exchange
TKS
Primary Office
- 2-7-17-1
- Akasaka, Minato-ku
- Tokyo, 107-8521
- Japan
+81 00-0000-0000
Tsumura & Company Stock Performance
(As of Friday Closing)
| Stock Price | Previous Close | 52 wk Range | Market Cap | Shares | Average Volume | EPS |
|---|---|---|---|---|---|---|
| $29.94 | $30.43 | $20.61 - $32.23 | $2.29B | 76.5M | 177K | $1.68 |
Tsumura & Company Financials Summary
|
In Thousands, USD |
TTM 30-Jun-2020 | FY 2020 31-Mar-2020 | FY 2019 31-Mar-2019 | FY 2018 31-Mar-2018 |
|---|---|---|---|---|
| EV | 2,106,744 | 1,881,454 | 2,169,408 | 2,345,696 |
| Revenue | 1,149,340 | 1,133,112 | 1,090,490 | 1,063,408 |
| EBITDA | 239,452 | 231,664 | 233,727 | 238,740 |
| Net Income | 128,574 | 126,552 | 131,619 | 130,840 |
| Total Assets | 2,905,811 | 2,878,072 | 2,591,300 | 2,751,286 |
| Total Debt | 615,478 | 603,925 | 448,144 | 608,733 |
Public Fundamental Data provided by Morningstar, Inc.
disclaimer
Tsumura & Company Valuation & Funding
| Deal Type | Date | Amount | Valuation/ EBITDA |
Post-Val | Status | Debt |
|---|
This information is available in the PitchBook Platform. To explore Tsumura & Company‘s full profile, request access.
Request a free trialTsumura & Company Executive Team (1)
| Name | Title | Board Seat | Contact Info |
|---|---|---|---|
| Terukazu Kato | President & Representative Director |
Tsumura & Company Signals
Growth Rate
0.80%
Weekly
Growth
Growth
Weekly Growth
0.80%, 93rd %ile
-35.5%.
530%
Size Multiple
219x
Median
Size Multiple
219x, 100th %ile
0.00x
0.95x.
413Kx
Key Data Points
Twitter Followers
5.5k
Similarweb Unique Visitors
15.0K
Majestic Referring Domains
314
PitchBook’s non-financial metrics help you gauge a company’s traction and growth using web presence and social reach.
Request a free trialTsumura & Company Investors
| Investor Name | Investor Type | Holding | Investor Since | Participating Rounds | Contact Info |
|---|
This information is available in the PitchBook Platform. To explore Tsumura & Company‘s full profile, request access.
Request a free trialTsumura & Company Investments (1)
| Company Name | Deal Date | Deal Type | Deal Size | Industry | Lead Partner |
|---|---|---|---|---|---|
| 0000 00 0 0000000 | 30-Nov-2017 | 00000 0000000 | Drug Discovery | 00000000 0000 |